There is both good news and bad news about prostate cancer screening. First, the bad news: the blood test involved, which measures a compound called prostate-specific antigen (PSA), is too inaccurate.

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

Millions of men could benefit from a faster 15-minute prostate cancer scan that paves the way to a national screening programme. The new MRI scan takes half the time of the current one and costs half ...

A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis. Prostate-specific antigen (PSA) ...

A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown. The PSA blood test checks the level of prostate-specific antigen, a marker for ...